Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Cutaneous amyloidosis: classification].

A P De Mesquita

    Medicina Cutanea Ibero-Latino-Americana
    |January 1, 1984
    PubMed
    Summary
    This summary is machine-generated.

    This study introduces a novel clinical classification for amyloidosis, focusing on cutaneous manifestations. It proposes new criteria, excluding traditional terms like primary or secondary classifications.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [How to prevent Hansen's disease].

    Hansenologia internationalis·1985
    Same author

    [Health education in Hansen's disease].

    Hansenologia internationalis·1983
    Same author

    [Hansen's disease: its image, education, integration and physician-patient relationship].

    Hansenologia internationalis·1979
    Same author

    [Dr. Ernani Agrícola (1883-1978)].

    Boletim da Divisao Nacional de Dermatologia Sanitaria·1978
    Same author

    [Framboesiform leishmaniasis].

    Anais brasileiros de dermatologia·1967
    Same author

    [Epidermodysplasia verriciformis (Lewandosvsky e Lutz) (E.V.)].

    Anais brasileiros de dermatologia·1966

    Area of Science:

    • Dermatology
    • Pathology
    • Internal Medicine

    Context:

    • Amyloidosis classification requires refinement to encompass all clinical presentations.
    • Cutaneous lesions are significant but often underrepresented in current amyloidosis typologies.
    • Existing classification systems for amyloidosis lack comprehensive inclusion of dermatological findings.

    Purpose:

    • To establish a new, unified clinical classification for amyloidosis.
    • To integrate all cutaneous manifestations of amyloidosis into a cohesive classificatory framework.
    • To propose alternative criteria for classifying amyloidosis, moving beyond traditional descriptors.

    Summary:

    • A new clinical classification for amyloidosis is proposed, encompassing all cutaneous lesions.

    Related Experiment Videos

  • The classification system rejects terms such as primary, secondary, or primitive as definitive criteria.
  • This approach aims for a more accurate and inclusive categorization of amyloidosis based on clinical presentation.

    • Impact:

    • This revised classification may improve diagnostic accuracy and patient stratification for amyloidosis.
    • It provides a more holistic understanding of amyloidosis, particularly its dermatological impact.
    • The proposed system offers a foundation for future research into amyloidosis pathogenesis and treatment.